Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 31

1.

Ultra-Low Power Sensor Devices for Monitoring Physical Activity and Respiratory Frequency in Farmed Fish.

Martos-Sitcha JA, Sosa J, Ramos-Valido D, Bravo FJ, Carmona-Duarte C, Gomes HL, Calduch-Giner JÀ, Cabruja E, Vega A, Ferrer MÁ, Lozano M, Montiel-Nelson JA, Afonso JM, Pérez-Sánchez J.

Front Physiol. 2019 May 29;10:667. doi: 10.3389/fphys.2019.00667. eCollection 2019.

2.

Duration of protection from live attenuated vs. sub unit HSV-2 vaccines in the guinea pig model of genital herpes: Reassessing efficacy using endpoints from clinical trials.

Bernstein DI, Cardin RD, Pullum DA, Bravo FJ, Kousoulas KG, Dixon DA.

PLoS One. 2019 Mar 27;14(3):e0213401. doi: 10.1371/journal.pone.0213401. eCollection 2019.

3.

The HSV-1 live attenuated VC2 vaccine provides protection against HSV-2 genital infection in the guinea pig model of genital herpes.

Bernstein DI, Pullum DA, Cardin RD, Bravo FJ, Dixon DA, Kousoulas KG.

Vaccine. 2019 Jan 3;37(1):61-68. doi: 10.1016/j.vaccine.2018.11.042. Epub 2018 Nov 22.

PMID:
30471955
4.

Replication-defective lymphocytic choriomeningitis virus vectors expressing guinea pig cytomegalovirus gB and pp65 homologs are protective against congenital guinea pig cytomegalovirus infection.

Cardin RD, Bravo FJ, Pullum DA, Orlinger K, Watson EM, Aspoeck A, Fuhrmann G, Guirakhoo F, Monath T, Bernstein DI.

Vaccine. 2016 Apr 12;34(17):1993-9. doi: 10.1016/j.vaccine.2016.03.005. Epub 2016 Mar 10.

PMID:
26973071
5.

Efficacy of N-methanocarbathymidine against genital herpes simplex virus type 2 shedding and infection in guinea pigs.

Bernstein DI, Bravo FJ, Pullum DA, Shen H, Wang M, Rahman A, Glazer RI, Cardin RD.

Antivir Chem Chemother. 2015 Feb;24(1):19-27. doi: 10.1177/2040206614566581.

6.

Inhibition of LSD1 reduces herpesvirus infection, shedding, and recurrence by promoting epigenetic suppression of viral genomes.

Hill JM, Quenelle DC, Cardin RD, Vogel JL, Clement C, Bravo FJ, Foster TP, Bosch-Marce M, Raja P, Lee JS, Bernstein DI, Krause PR, Knipe DM, Kristie TM.

Sci Transl Med. 2014 Dec 3;6(265):265ra169. doi: 10.1126/scitranslmed.3010643.

7.

An adjuvanted herpes simplex virus 2 subunit vaccine elicits a T cell response in mice and is an effective therapeutic vaccine in Guinea pigs.

Skoberne M, Cardin R, Lee A, Kazimirova A, Zielinski V, Garvie D, Lundberg A, Larson S, Bravo FJ, Bernstein DI, Flechtner JB, Long D.

J Virol. 2013 Apr;87(7):3930-42. doi: 10.1128/JVI.02745-12. Epub 2013 Jan 30.

8.

Topical SMIP-7.7, a toll-like receptor 7 agonist, protects against genital herpes simplex virus type-2 disease in the guinea pig model of genital herpes.

Bernstein DI, Cardin RD, Bravo FJ, Earwood J, Clark JR, Li Y, Mishra P, Li C, Nayak BP, Miller AT, Wu TY, Cooke MP, Valiante NM.

Antivir Chem Chemother. 2014 Apr 11;23(5):189-96. doi: 10.3851/IMP2499.

PMID:
23232327
9.

N-Methanocarbathymidine is more effective than acyclovir for treating neonatal herpes simplex virus infection in guinea pigs.

Bernstein DI, Bravo FJ, Clark JR, Earwood JD, Rahman A, Glazer R, Cardin RD.

Antiviral Res. 2011 Nov;92(2):386-8. doi: 10.1016/j.antiviral.2011.08.021. Epub 2011 Sep 7.

10.

Effects of herpes simplex virus type 2 glycoprotein vaccines and CLDC adjuvant on genital herpes infection in the guinea pig.

Bernstein DI, Earwood JD, Bravo FJ, Cohen GH, Eisenberg RJ, Clark JR, Fairman J, Cardin RD.

Vaccine. 2011 Mar 3;29(11):2071-8. doi: 10.1016/j.vaccine.2011.01.005. Epub 2011 Jan 14.

11.

Oral hexadecyloxypropyl-cidofovir therapy in pregnant guinea pigs improves outcome in the congenital model of cytomegalovirus infection.

Bravo FJ, Bernstein DI, Beadle JR, Hostetler KY, Cardin RD.

Antimicrob Agents Chemother. 2011 Jan;55(1):35-41. doi: 10.1128/AAC.00971-10. Epub 2010 Nov 15.

12.

Recurrent vaginal shedding of herpes simplex type 2 virus in the mouse and effects of antiviral therapy.

Farley N, Bernstein DI, Bravo FJ, Earwood J, Sawtell N, Cardin RD.

Antiviral Res. 2010 May;86(2):188-95. doi: 10.1016/j.antiviral.2010.02.317. Epub 2010 Feb 16.

13.

Amphipathic DNA polymers exhibit antiviral activity against systemic murine Cytomegalovirus infection.

Cardin RD, Bravo FJ, Sewell AP, Cummins J, Flamand L, Juteau JM, Bernstein DI, Vaillant A.

Virol J. 2009 Dec 2;6:214. doi: 10.1186/1743-422X-6-214.

14.

The adjuvant CLDC increases protection of a herpes simplex type 2 glycoprotein D vaccine in guinea pigs.

Bernstein DI, Farley N, Bravo FJ, Earwood J, McNeal M, Fairman J, Cardin R.

Vaccine. 2010 May 7;28(21):3748-53. doi: 10.1016/j.vaccine.2009.10.025. Epub 2009 Oct 24.

15.

Potent adjuvant activity of cationic liposome-DNA complexes for genital herpes vaccines.

Bernstein DI, Cardin RD, Bravo FJ, Strasser JE, Farley N, Chalk C, Lay M, Fairman J.

Clin Vaccine Immunol. 2009 May;16(5):699-705. doi: 10.1128/CVI.00370-08. Epub 2009 Mar 11.

16.

A model of human cytomegalovirus infection in severe combined immunodeficient mice.

Bravo FJ, Cardin RD, Bernstein DI.

Antiviral Res. 2007 Nov;76(2):104-10. Epub 2007 Jul 10.

17.

Effect of maternal treatment with cyclic HPMPC in the guinea pig model of congenital cytomegalovirus infection.

Bravo FJ, Cardin RD, Bernstein DI.

J Infect Dis. 2006 Feb 15;193(4):591-7. Epub 2006 Jan 13.

PMID:
16425139
18.

Protection against congenital cytomegalovirus infection and disease in guinea pigs, conferred by a purified recombinant glycoprotein B vaccine.

Schleiss MR, Bourne N, Stroup G, Bravo FJ, Jensen NJ, Bernstein DI.

J Infect Dis. 2004 Apr 15;189(8):1374-81. Epub 2004 Apr 1.

PMID:
15073673
19.

An animal model of neonatal cytomegalovirus infection.

Bravo FJ, Bourne N, Schleiss MR, Bernstein DI.

Antiviral Res. 2003 Sep;60(1):41-9.

PMID:
14516920
20.

Herpes simplex virus (HSV) type 2 glycoprotein D subunit vaccines and protection against genital HSV-1 or HSV-2 disease in guinea pigs.

Bourne N, Bravo FJ, Francotte M, Bernstein DI, Myers MG, Slaoui M, Stanberry LR.

J Infect Dis. 2003 Feb 15;187(4):542-9. Epub 2003 Feb 7.

PMID:
12599070
21.

Quantitative-competitive PCR monitoring of viral load following experimental guinea pig cytomegalovirus infection.

Schleiss MR, Bourne N, Bravo FJ, Jensen NJ, Bernstein DI.

J Virol Methods. 2003 Mar;108(1):103-10.

PMID:
12565160
22.

Preconception immunization with a cytomegalovirus (CMV) glycoprotein vaccine improves pregnancy outcome in a guinea pig model of congenital CMV infection.

Bourne N, Schleiss MR, Bravo FJ, Bernstein DI.

J Infect Dis. 2001 Jan 1;183(1):59-64. Epub 2000 Nov 21.

PMID:
11087203
23.
24.

Effect of age and route of inoculation on outcome of neonatal herpes simplex virus infection in guinea pigs.

Mani CS, Bravo FJ, Stanberry LR, Myers MG, Bernstein DI.

J Med Virol. 1996 Mar;48(3):247-52.

PMID:
8801285
25.

Effect of antibody alone and combined with acyclovir on neonatal herpes simplex virus infection in guinea pigs.

Bravo FJ, Bourne N, Harrison CJ, Mani C, Stanberry LR, Myers MG, Bernstein DI.

J Infect Dis. 1996 Jan;173(1):1-6.

PMID:
8537645
26.

Effect of passive antibody on congenital cytomegalovirus infection in guinea pigs.

Bratcher DF, Bourne N, Bravo FJ, Schleiss MR, Slaoui M, Myers MG, Bernstein DI.

J Infect Dis. 1995 Oct;172(4):944-50.

PMID:
7561214
27.

Neonatal herpes simplex virus infection: pathogenesis and treatment in the guinea pig.

Bravo FJ, Myers MG, Stanberry LR.

J Infect Dis. 1994 May;169(5):947-55.

PMID:
8169425
28.

Evaluation of HPMPC therapy for primary and recurrent genital herpes in mice and guinea pigs.

Bravo FJ, Stanberry LR, Kier AB, Vogt PE, Kern ER.

Antiviral Res. 1993 May;21(1):59-72.

PMID:
8391249
29.

Capsaicin-sensitive peptidergic neurons are involved in the zosteriform spread of herpes simplex virus infection.

Stanberry LR, Bourne N, Bravo FJ, Bernstein DI.

J Med Virol. 1992 Oct;38(2):142-6.

PMID:
1334128
30.

Assessment of a selective inhibitor of herpes simplex virus thymidine kinase (L-653,180) as therapy for experimental recurrent genital herpes.

Bourne N, Bravo FJ, Ashton WT, Meurer LC, Tolman RL, Karkas JD, Stanberry LR.

Antimicrob Agents Chemother. 1992 Sep;36(9):2020-4.

31.

Recurrent genital herpes in the guinea pig augmented by ultraviolet irradiation: effects of treatment with acyclovir.

Stanberry LR, Harrison CJ, Bravo FJ, Childs F, Reece AL, Bernstein DI.

Antiviral Res. 1990 May;13(5):227-35.

PMID:
2396831

Supplemental Content

Loading ...
Support Center